X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs DIVIS LABORATORIES - Comparison Results

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE DIVIS LABORATORIES SUVEN LIFE/
DIVIS LABORATORIES
 
P/E (TTM) x 13.9 34.2 40.7% View Chart
P/BV x 3.3 5.5 59.7% View Chart
Dividend Yield % 0.5 0.9 59.2%  

Financials

 SUVEN LIFE   DIVIS LABORATORIES
EQUITY SHARE DATA
    SUVEN LIFE
Mar-17
DIVIS LABORATORIES
Mar-17
SUVEN LIFE/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs2291,222 18.7%   
Low Rs151784 19.3%   
Sales per share (Unadj.) Rs42.7153.1 27.9%  
Earnings per share (Unadj.) Rs6.939.9 17.1%  
Cash flow per share (Unadj.) Rs8.544.6 19.1%  
Dividends per share (Unadj.) Rs1.0010.00 10.0%  
Dividend yield (eoy) %0.51.0 52.8%  
Book value per share (Unadj.) Rs52.4201.8 26.0%  
Shares outstanding (eoy) m127.28265.47 47.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.46.6 67.8%   
Avg P/E ratio x27.725.1 110.3%  
P/CF ratio (eoy) x22.222.5 98.9%  
Price / Book Value ratio x3.65.0 72.9%  
Dividend payout %14.625.0 58.3%   
Avg Mkt Cap Rs m24,158266,266 9.1%   
No. of employees `0001.09.7 10.4%   
Total wages/salary Rs m5224,687 11.1%   
Avg. sales/employee Rs Th5,349.74,175.0 128.1%   
Avg. wages/employee Rs Th513.5481.5 106.6%   
Avg. net profit/employee Rs Th858.11,089.3 78.8%   
INCOME DATA
Net Sales Rs m5,43540,643 13.4%  
Other income Rs m211749 28.2%   
Total revenues Rs m5,64641,392 13.6%   
Gross profit Rs m1,29114,460 8.9%  
Depreciation Rs m2141,233 17.4%   
Interest Rs m5723 251.3%   
Profit before tax Rs m1,23113,953 8.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3593,349 10.7%   
Profit after tax Rs m87210,604 8.2%  
Gross profit margin %23.735.6 66.7%  
Effective tax rate %29.224.0 121.5%   
Net profit margin %16.026.1 61.5%  
BALANCE SHEET DATA
Current assets Rs m4,91740,105 12.3%   
Current liabilities Rs m1,1866,595 18.0%   
Net working cap to sales %68.682.5 83.3%  
Current ratio x4.16.1 68.2%  
Inventory Days Days62119 52.4%  
Debtors Days Days3181 38.1%  
Net fixed assets Rs m3,15419,995 15.8%   
Share capital Rs m127531 24.0%   
"Free" reserves Rs m6,54353,043 12.3%   
Net worth Rs m6,67053,574 12.5%   
Long term debt Rs m2590-   
Total assets Rs m8,15761,585 13.2%  
Interest coverage x22.7618.4 3.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.7 101.0%   
Return on assets %11.417.3 66.0%  
Return on equity %13.119.8 66.0%  
Return on capital %18.626.1 71.2%  
Exports to sales %00-   
Imports to sales %025.2 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA10,259 0.0%   
Fx inflow Rs m4,99635,384 14.1%   
Fx outflow Rs m95910,399 9.2%   
Net fx Rs m4,03724,985 16.2%   
CASH FLOW
From Operations Rs m1,08811,493 9.5%  
From Investments Rs m-3,107-11,372 27.3%  
From Financial Activity Rs m-300-93 322.4%  
Net Cashflow Rs m-2,31928 -8,164.1%  

Share Holding

Indian Promoters % 63.4 52.0 121.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 11.8 -  
FIIs % 0.0 19.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 17.2 212.2%  
Shareholders   37,287 31,796 117.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   PIRAMAL ENTERPRISES  GSK PHARMA  DR. DATSONS LABS  DR. REDDYS LAB  NOVARTIS  

Compare SUVEN LIFE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day Flat; Auto Stocks Top Gainers(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a positive note.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


May 22, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS